Trial · NCT02325713
Results by group243
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 243
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Area Under the Plasma Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-inf) Adjusted for the Actual Administered Dose (AUC0-inf, Adj) of L-Praziquantel (L-PZQ) | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | 1969.6 | Geometric Coefficient of Variation 47.2 | Hour*nanograms per milliliter (h*ng/mL) | |
| Area Under the Plasma Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-inf) Adjusted for the Actual Administered Dose (AUC0-inf, Adj) of L-Praziquantel (L-PZQ) | Treatment B: 40 mg/kg Cysticide Tablet After Meal | 2047.9 | Geometric Coefficient of Variation 60.2 | Hour*nanograms per milliliter (h*ng/mL) | |
| Area Under the Plasma Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-inf) Adjusted for the Actual Administered Dose (AUC0-inf, Adj) of L-Praziquantel (L-PZQ) | Treatment C1: 20 mg/kg Test ODT-PZQ After Meal | 345.4 | Geometric Coefficient of Variation 69.5 | Hour*nanograms per milliliter (h*ng/mL) | |
| Area Under the Plasma Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-inf) Adjusted for the Actual Administered Dose (AUC0-inf, Adj) of L-Praziquantel (L-PZQ) | Treatment C2: 60 mg/kg Test ODT-PZQ After Meal | 4871.3 | Geometric Coefficient of Variation 42.2 | Hour*nanograms per milliliter (h*ng/mL) | |
| Area Under the Plasma Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-inf) Adjusted for the Actual Administered Dose (AUC0-inf, Adj) of L-Praziquantel (L-PZQ) | Treatment D1: 40 mg/kg Test ODT-PZQ Without Meal | 924.9 | Geometric Coefficient of Variation 67.7 | Hour*nanograms per milliliter (h*ng/mL) | |
| Area Under the Plasma Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-inf) Adjusted for the Actual Administered Dose (AUC0-inf, Adj) of L-Praziquantel (L-PZQ) | Treatment D2: 40 mg/kg Cysticide Crushed Tablets After Meal | 1537.7 | Geometric Coefficient of Variation 70.6 | Hour*nanograms per milliliter (h*ng/mL) | |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | L-PZQ | 881.3 | Geometric Coefficient of Variation 57.2 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment B: 40 mg/kg Cysticide Tablet After Meal | L-PZQ | 762.6 | Geometric Coefficient of Variation 59.5 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment C1: 20 mg/kg Test ODT-PZQ After Meal | L-PZQ | 154.6 | Geometric Coefficient of Variation 80.4 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment C2: 60 mg/kg Test ODT-PZQ After Meal | L-PZQ | 1548 | Geometric Coefficient of Variation 32.6 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment D1: 40 mg/kg Test ODT-PZQ Without Meal | L-PZQ | 189.3 | Geometric Coefficient of Variation 104.0 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment D2: 40 mg/kg Cysticide Crushed Tablets After Meal | L-PZQ | 446.3 | Geometric Coefficient of Variation 87.6 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | D-PZQ | 2330 | Geometric Coefficient of Variation 30.7 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment B: 40 mg/kg Cysticide Tablet After Meal | D-PZQ | 2179 | Geometric Coefficient of Variation 33.0 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment C1: 20 mg/kg Test ODT-PZQ After Meal | D-PZQ | 786.3 | Geometric Coefficient of Variation 41.5 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment C2: 60 mg/kg Test ODT-PZQ After Meal | D-PZQ | 3234 | Geometric Coefficient of Variation 20.0 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment D1: 40 mg/kg Test ODT-PZQ Without Meal | D-PZQ | 838.5 | Geometric Coefficient of Variation 65.7 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment D2: 40 mg/kg Cysticide Crushed Tablets After Meal | D-PZQ | 1556 | Geometric Coefficient of Variation 35.8 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | Racemate PZQ | 3250 | Geometric Coefficient of Variation 34.6 | ng/mL |
| Maximum Observed Concentration in Plasma (Cmax) Adjusted for the Actual Administered Dose (Cmax, Adj) of L-PZQ, D-PZQ and Racemate PZQ | Treatment B: 40 mg/kg Cysticide Tablet After Meal | Racemate PZQ | 2974 | Geometric Coefficient of Variation 37.2 | ng/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02325713/results